Pigmented lesion treatment laser ULTRApulse® Alpha

scar removalinflammatory skin diseases treatmentsurgical

Overview
ULTRApulse Alpha is a CO2 fractional ablative laser platform for clinical skin resurfacing and surgical dermatology. Designed for both experienced operators and clinicians new to ablative CO2 treatments, the system provides multiple fractional modes, collimated and focused handpieces, and embedded presets to streamline treatment setup and workflow.

Key Benefits & Features

• Multiple fractional modes for targeted indications (DeepFX™, ActiveFX™, GentleFX™, MaxFX™, LiteFX™, SCAAR FX™).
• BrushFX™ and CoolScan™ technologies to control scan patterns and enhance patient comfort.
• TrueSpot™ collimated 2.0 mm handpiece and IncisionFX™ focused handpieces (0.2 mm & 1.0 mm) for precise ablation and incisions.
• High ablation-to-coagulation performance enabling deeper penetration with lower energy and shorter pulses to limit thermal spread.
• SCAAR FX™ single-pulse mode for deepest impact (up to 4 mm) suitable for thick lesions and advanced scar revision.
• Very short pulse durations (shorter than tissue relaxation time) to minimize collateral thermal damage and support faster healing.

Scanners & Handpieces / Scanning Modes

• DeepFX™ / DeepFX™ High — fractional impact for fine lines, wrinkles and acne scars; DeepFX High for deeper lesions.
• SCAAR FX™ — deepest single-pulse mode for thick, complex lesions and scar revision.
• ActiveFX™, LiteFX™, GentleFX™, MaxFX™ — ablative and sub-ablative fractional settings for texture, pigment and dyschromia management.
• TrueSpot™ / PreciseFX™ — collimated 2.0 mm handpiece for fast, uniform ablation/coagulation with consistent fluence.
• IncisionFX™ / focused incisional handpieces — 0.2 mm & 1.0 mm options for clean, precise incisions and laser-assisted eyelid procedures.

Treatments & Clinical Uses

• Fractional ablative skin resurfacing for improvement of texture, tone and laxity; notable single-session change for selected indications.
• Scar revision (traumatic, atrophic, restrictive contractures) using combined ablation and coagulation modes including SCAAR FX™.
• Acne scar management with settings for deep, long-standing scars.
• Removal of syringomas and superficial lesions with limited scarring risk.
• Laser-assisted blepharoplasty: incision and surface renewal with reduced bleeding.
• Rhinophyma reduction and precise surgical debulking with controlled hemostasis.
• Targeted treatment of dyschromia and pigment irregularities.

Clinical Evidence
ULTRApulse Alpha modes and fractional CO2/ablative approaches are supported by multiple peer-reviewed studies and consensus recommendations for indications including atrophic acne scars, traumatic scars, post-surgical scar contractures and selected lesion management. Published clinical data and expert reports are available to support mode selection and expected outcomes.

Media
Educational videos, clinical case libraries and procedural demonstrations are available to illustrate device capabilities, workflow and clinical outcomes with ULTRApulse Alpha.

Technical specifications

• Commercial name: ULTRApulse Alpha (CO2 fractional / ablative laser platform).
• Main modes: DeepFX™, DeepFX™ High, SCAAR FX™, ActiveFX™, LiteFX™, GentleFX™, MaxFX™, TrueSpot™, IncisionFX™, PreciseFX™, BrushFX™, CoolScan™.
• SCAAR FX™: single-pulse impact up to 4 mm (for deep/thick lesions).
• Penetration examples (histology reference): 60 mJ → ≈ 2,200 µm; 100 mJ → ≈ 3,470 µm; 150 mJ → ≈ 3,900 µm.
• Handpieces: collimated 2.0 mm TrueSpot™; focused incisional handpieces 0.2 mm & 1.0 mm.
• Pulse characteristics: very short pulse durations designed below tissue relaxation time to reduce thermal damage and accelerate healing.
• User interface: clinician-oriented interface with embedded presets and protocol automations for reproducible workflow.
• Primary indications: ablative skin resurfacing, scar revision, acne scars, syringomas, blepharoplasty, fractional ablative resurfacing, rhinophyma, dyschromia.